Stocktoria
HUTCHMED (China) Ltd HCM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2006-05-19
HUTCHMED (China) Ltd financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $548.5M | $630.2M | $838.0M | $426.4M | $356.1M |
| R&D expense | $148.3M | $212.1M | $302.0M | $386.9M | $299.1M |
| Operating income | -$39.2M | -$43.7M | $18.4M | -$407.7M | -$328.3M |
| Interest expense | — | — | $759,000 | $652,000 | $592,000 |
| Income tax | $63.6M | $7.2M | $4.5M | -$283,000 | $11.9M |
| Net income | $456.9M | $37.7M | $100.8M | -$360.8M | -$194.6M |
| EPS (diluted) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 |
| Operating cash flow | -$64.7M | $497,000 | $219.3M | -$268.6M | -$204.2M |
| Free cash flow | -$78.8M | -$17.4M | $186.6M | -$305.3M | -$220.6M |
| Cash & equivalents | $71.3M | $154.0M | $283.6M | $313.3M | $377.5M |
| Inventory | $41.1M | $50.4M | $50.3M | $56.7M | $35.8M |
| Total assets | $1.8B | $1.3B | $1.3B | $1.0B | $1.4B |
| Total liabilities | $501.8M | $502.3M | $536.4M | $392.6M | $333.1M |
| Shareholders' equity | $1.3B | $771.9M | $743.4M | $636.9M | $1.0B |
Source: SEC EDGAR filings · CIK 0001648257 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.